Century Therapeutics IPSC
NASDAQ IPSC
$1.65 -0.02 (-1.20%)
At close: Sep 29, 2026 · 4:00 PM EDT

Century Therapeutics (IPSC) Interest Expenses (2020 - 2023)

Updated

Century Therapeutics' Interest Expenses was $540,000 in FY2023.

Analysis

Century Therapeutics (IPSC) Interest Expenses (2020 - 2023) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Int Expense (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn 281.00 Mn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn -
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn -
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn -462.00 Mn
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn -435.00 Mn
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn 673.00 Mn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn 247.00 Mn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn -
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn -
10 Century Therapeutics 301.51 Mn -202.86 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2023 136,000.00
Mar 31, 2023 404,000.00
Sep 30, 2022 373,000.00
Jun 30, 2022 330,000.00
Mar 31, 2022 314,000.00
Sep 30, 2021 322,000.00
Jun 30, 2021 318,000.00
Sep 30, 2020 59,000.00
API Access

Century Therapeutics Interest Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=interest-expenses&ticker=IPSC&period=max&api_key=YOUR_API_KEY